Flu Vaccine Candidate Elicits Enhanced Immune Response

JAMA. 2021 Nov 9;326(18):1784. doi: 10.1001/jama.2021.19385.
No abstract available

Publication types

  • News

MeSH terms

  • Aged
  • Clinical Trials, Phase III as Topic
  • Humans
  • Immunogenicity, Vaccine*
  • Influenza Vaccines / immunology*
  • Influenza, Human / prevention & control*
  • Nanoparticles
  • Vaccines, Inactivated / immunology

Substances

  • Influenza Vaccines
  • Vaccines, Inactivated